6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one is an impurity of Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or other parts of the body in patients who have already been treated with at least one other chemotherapy medication. Erlotinib is in a class of medications called kinase inhibitors.
Additional information on 6 | 6' | 7 | 7'-Tetrakis(2-methoxyethoxy)-4H-[3 | 4'-biquinazolin]-4-one
6, 6', 7, 7'-Tetrakis(2-methoxyethoxy)-4H-[3, 4'-biquinazolin]-4-one
“Erlotinib: MedlinePlus Drug Information.” Medlineplus.gov, 2017, medlineplus.gov/druginfo/meds/a605008.html.
Other products related to erlotinib
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|